Adaptive Biotechnologies
ADPT
#6540
Rank
S$1.16 B
Marketcap
S$29.15
Share price
6.86%
Change (1 day)
76.84%
Change (1 year)

Market capitalization of Adaptive Biotechnologies (ADPT)

Market cap: S$1.16 Billion

As of August 2026 Adaptive Biotechnologies has a market cap of S$1.16 Billion. This makes Adaptive Biotechnologies the world's 6540th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptive Biotechnologies from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026S$1.16 B-64.37%
2025S$3.27 B159.42%
2024S$1.26 B34.68%
2023S$0.93 B-36.04%
2022S$1.46 B-72.64%
2021S$5.35 B-49.96%
2020S$10.69 B111.79%
2019S$5.05 B

End of Day market cap according to different sources

On Aug 30th, 2026 the market cap of Adaptive Biotechnologies was reported to be:

S$5.11 Billion
by Nasdaq info icon info icon
S$1.16 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HCA Healthcare
HCA
S$114.98 B 9,760.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
S$2.97 B 155.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Community Health Systems
CYH
S$0.51 B-55.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Select Medical Holdings
SEM
S$2.60 B 123.33%๐Ÿ‡บ๐Ÿ‡ธ USA